Source: https://patents.google.com/patent/US9120872
Timestamp: 2018-03-19 22:28:08
Document Index: 12309868

Matched Legal Cases: ['Application No. 10012382', 'Application No. 04806668', 'Application No. 10012382', 'Application No. 04806668', 'Application No. 07110777', 'Application No. 04806668', 'Application No. 04806668', 'Application No. 10012382', 'Application No. 04806668', '§ 2', 'Application No. 10012382', 'Application No. 07110777', '§ 3', '§ 2', 'Application No. 04806668', 'Application No. 04806668', 'Application No. 04806668', 'Application No. 04806668', 'Application No. 04806668', 'Application No. 04806668', 'Application No. 07110777']

US9120872B2 - Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same - Google Patents
US9120872B2
US9120872B2 US12912809 US91280910A US9120872B2 US 9120872 B2 US9120872 B2 US 9120872B2 US 12912809 US12912809 US 12912809 US 91280910 A US91280910 A US 91280910A US 9120872 B2 US9120872 B2 US 9120872B2
US20110038828A1 (en )
US20110038828A1 true US20110038828A1 (en) 2011-02-17
US9120872B2 true US9120872B2 (en) 2015-09-01
US20150030580A1 (en) * 2003-12-22 2015-01-29 Regentis Biomaterials Ltd. Pegylated fibrinogen precursor molecule
EP0605797A1 (en) 1992-12-17 1994-07-13 BEHRINGWERKE Aktiengesellschaft Synthetic peptides, antibodies directed against them and their use
EP0976759A2 (en) 1998-07-10 2000-02-02 ZLB Zentrallaboratorium Blutspendedienst SRK Preparation of protein formulations with reduced content of aggregates
WO2001053324A2 (en) 2000-01-20 2001-07-26 Hadasit Medical Research Services & Development Company Ltd. Novel haptotactic peptides
US20040082511A1 (en) 2001-01-18 2004-04-29 Georg Watzek Drug composition for the promotion of tissue regeneration
WO2004041298A1 (en) 2002-11-03 2004-05-21 Hapto Biotech, Inc. Liposomal composition comprising haptotactic peptides
WO2008126092A2 (en) 2007-04-16 2008-10-23 Regentis Biomaterials Ltd. Compositions and methods for scaffold formation
CN101421359B (en) * 2006-03-02 2013-06-26 日本化药株式会社 Dye-sensitized photoelectric conversion element
US20150030580A1 (en) 2003-12-22 2015-01-29 Regentis Biomaterials Ltd. Pegylated fibrinogen precursor molecule
US20120020911A1 (en) 2003-12-22 2012-01-26 Regentis Biomaterials Ltd. Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same
Almany et al. "Biosynthetic Hydrogel Scaffolds Made From Fibrinogen and Polyethylene Glycol for 3D Cell Cultures", Biomaterials, 26: 2467-2477, 2005.
Almany et al. "Biosynthetic Hydrogel Scaffolds Made From Fibrinogen and Polyethylene Glycol for 3D Cell Cultures", Biomaterials, XP004673411, 26(15): 2467-2477, May 15, 2005. § [03.5], [0004], p. 2471, Table 1.
Communication Pursuant to Article 94(3) EPC Dated Apr. 2, 2012 From the European Patent Office Re. Application No. 10012382.7.
Communication Pursuant to Article 94(3) EPC Dated Dec. 2, 2010 From the European Patent Office Re. Application No. 04806668.2.
Communication Pursuant to Article 94(3) EPC Dated Feb. 10, 2015 From the European Patent Office Re. Application No. 10012382.7.
Communication Pursuant to Article 94(3) EPC Dated Jan. 5, 2009 From the European Patent Office Re.: Application No. 04806668.2.
Communication Pursuant to Article 94(3) EPC Dated Jul. 25, 2008 From the European Patent Office Re.: Application No. 07110777.5.
Communication Pursuant to Article 94(3) EPC Dated Jul. 6, 2009 From the European Patent Office Re.: Application No. 04806668.2.
Communication Pursuant to Article 96(2) EPC Dated Dec. 11, 2006 From the European Patent Office Re.: Application No. 04806668.2.
Communication Pursuant to Rules 70(2) and 70a(2) EPC and Reference to Rule 39(1) EPC Dated Jun. 28, 2011 From the European Patent Office Re. Application No. 10012382.7.
Communication Under Rule 71(3) EPC Dated Nov. 2, 2011 From the European Patent Office Re.: Application No. 04806668.2.
Deible et al. "Molecular Barriers to Biomaterial Thrombosis by Modification of Surface Proteins With Polyethylene Glycol", Biomaterials, 19: 1885-1893, 1998.
Dikovsky et al. "The Effect of Structural Alterations of PEG-Fibrinogen Hydrogel Scaffolds on 3-D Cellular Morphology and Cellular Migration", Biomaterials, XP005193217, 27(8): 1496-1506, Oct. 21, 2005. Abstract, p. 1497, § 2.1, 2.2.
D'Urso et al. "Poly(Ethylene Glycol)-Serum Albumin Hydrogel as Matrix for Enzyme Immobilization: Biomedical Applications", Art. Cells, Blood Subs., and Biotech., 23(5): 587-595, 1995.
European Search Report and the European Search Opinion Dated May 20, 2011 From the European Patent Office Re. Application No. 10012382.7.
European Search Report Dated Oct. 22, 2007 From the European Patent Office Re.: Application No. 07110777.5.
Final Official Action Dated Feb. 26, 2014 From the US Patent and Trademark Office Re.: U.S. Appl. No. 13/181,562.
Gayet et al. "Drug Release From New Bioartificial Hydrogel", Art. Cells, Blood Subs., and Immob Biotech., 23(5): 605-611, 1995.
Halstenberg et al. "Biologically Engineered Protein-Graft-Poly(Ethylene Glycol) Hydrogels: A Cell Adhesive and Plasmin-Degradable Biosynthetic Material for Tissue Repair", Biomacromolecules, XP002454079, 3(4): 710-723, Jul. 2002. Abstract, p. 713, col. 2, § 3-p. 714, col. 1, § 2.
Hooftman et al. "Review: Poly(Ethylene Glycol)s With Reactive Endgroups. II. Practical Consideratiion for the Preparation of Protein-PEG Conjugates", Journal of Bioactive and Compatible Polymers, 11: 135-159, 1996.
International Preliminary Report on Patentability Dated Jul. 6, 2006 From the International Bureau of WIPO Re.: Application No. PCT/IL2004/001136.
International Search Report Dated Aug. 2, 2005 From the International Searching Authority Re.: Application No. PCT/IL2004/001136.
International Search Report Dated Jun. 1, 2005 From the International Searching Authority Re.: Application No. PCT/IL2004/001136.
Interview Summary Dated Oct. 18, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/472,437.
Invitation Pursuant to Article 94(3) and Rule 71(1) EPC Dated Jun. 10, 2010 From the European Patent Office Re. Application No. 04806668.2.
Invitation Pursuant to Article 94(3) and Rule 71(1) EPC Dated May 19, 2011 From the European Patent Office Re. Application No. 04806668.2.
Li et al. "Synthesis of Polyethylene Glycol (PEG) Derivatives and PEGylated-Peptide Biopolymer Conjugates", Biomacromolecules, 4: 1055-1067, 2003.
Meyers et al. "A Fibrin Adhesive Seal for the Repair of Osteochondral Fracture Fragments", Clinical Orthopaedics and Related Research, 182: 258-263, Jan.-Feb. 1984.
Notice of Allowance Dated Apr. 11, 2011 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/472,437.
Notice of Allowance Dated Jul. 26, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/472,520.
Notice of Allowance Dated Jun. 4, 2014 From the US Patent and Trademark Office Re. U.S. Appl. No. 13/181,562.
Official Action Dated Apr. 28, 2008 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/472,520.
Official Action Dated Aug. 15, 2013 From the US Patent and Trademark Office Re. U.S. Appl. No. 13/181,562.
Official Action Dated Aug. 7, 2008 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/472,437.
Official Action Dated Feb. 4, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/472,520.
Official Action Dated Jan. 21, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/472,437.
Official Action Dated Jan. 3, 2011 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/472,437.
Official Action Dated Jan. 8, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/472,437.
Official Action Dated Jul. 22, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/472,520.
Official Action Dated Jun. 15, 2007 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/472,520.
Official Action Dated Jun. 29, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/472,437.
Official Action Dated Nov. 12, 2008 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/472,520.
Official Action Dated Oct. 4, 2007 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/472,520.
Official Action Dated Sep. 17, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/472,437.
Pflüger et al. "Untersuchungen über das Einwachsen von Knochengewebe in poröse Metallimplantate", Wiener Klinische Wochenschrift, 91(14): 482-487, Jul. 13, 1979. & Translation Into English.
Response Dated Apr. 21, 2010 to Official Action of Jan. 21, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/472,437.
Response Dated Apr. 4, 2011 to Official Action of Jan. 3, 2011 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/472,437.
Response Dated Dec. 16, 2009 to Official Action of Sep. 17, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/472,437.
Response Dated Jan. 28, 2010 to Communication Pursuant to Article 94(3) EPC of Jul. 6, 2009 From the European Patent Office Re.: Application No. 04806668.2.
Response Dated Jul. 29, 2011 to Invitation Pursuant to Article 94(3) and Rule 71(1) EPC of May 19, 2011 From the European Patent Office Re. Application No. 04806668.2.
Response Dated Mar. 4, 2011 to Communication Pursuant to Article 94(3) EPC of Dec. 2, 2010 From the European Patent Office Re. Application No. 04806668.2.
Response Dated May 3, 2010 to Official Action of Feb. 4, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/472,520.
Response Dated Oct. 18, 2010 to Invitation Pursuant to Article 94(3) and Rule 71(1) EPC of Jun. 10, 2010 From the European Patent Office Re. Application No. 04806668.2.
Response Dated Oct. 19, 2009 to Official Action of Jul. 22, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/472,520.
Response Dated Oct. 28, 2010 to Official Action of Jun. 29, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/472,437.
Restriction Official Action Dated Mar. 12, 2013 From the US Patent and Trademark Office Re. U.S. Appl. No. 13/181,562.
Restriction Official Action Dated Mar. 13, 2015 From the US Patent and Trademark Office Re. U.S. Appl. No. 14/512,525.
Seliktar et al. "MMP-2 Sensitive, VEGF-Bearing Bioactive Hydrogels for Promotion of Vascular Healing", Journal of Biomedical Materials Research, Part. A, 68(4): 704-716, 2004.
Summons to Attend Oral Proceedings Pursuant to Rule 115(1) EPC Dated Jan. 28, 2013 From the European Patent Office Re. Application No. 07110777.5.
Veronese "Peptide and Protein PEGylation: A Review of Problems and Solutions", Biomaterials, 22: 405-417, 2001.
Wells "Additivity of Mutational Effects in Proteins", Perspectives in Biochemistry, Biochemistry, 29(37): 8509-8517, Sep. 18, 1990.
Written Opinion Dated Jun. 1, 2005 From the International Searching Authority Re.: Application No. PCT/IL2004/001136.
Zalipsky "Chemistry of Polyethylene Glycol Conjugates With Biologically Active Molecules", Advanced Drug Delivery Reviews, 16: 157-182, 1995.
US9474830B2 (en) * 2003-12-22 2016-10-25 Regentis Biomaterials Ltd. PEGylated fibrinogen precursor molecule
US20110038828A1 (en) 2011-02-17 application
US20030012818A1 (en) 2003-01-16 Drug delivery matrices to enhance wound healing